Literature DB >> 24928986

Acute and chronic B cell depletion disrupts CD4+ and CD8+ T cell homeostasis and expansion during acute viral infection in mice.

Jacquelyn M Lykken1, David J DiLillo1, Eric T Weimer1, Susanne Roser-Page2, Mark T Heise3, Jason M Grayson4, M Neale Weitzmann5, Thomas F Tedder6.   

Abstract

B cells provide humoral protection against pathogens and promote cellular immunity through diverse nonclassical effector functions. To assess B cell function in promoting T cell homeostasis, mature B cells were either acutely or chronically depleted in mice using CD20 mAb. Acute B cell depletion in either 2- or 4-mo-old mice significantly reduced spleen and lymph node CD4(+) and CD8(+) T cell numbers, including naive, activated, and Foxp3(+)CD25(+)CD4(+) regulatory T cell subsets. The numbers of IFN-γ- and TNF-α-producing T cells were also significantly reduced. Chronic B cell depletion for 6 mo in aged naive mice resulted in a 40-70% reduction in activated CD4(+) and CD8(+) T cell numbers and 20-50% reductions in IFN-γ-producing T cells. Therefore, B cells were necessary for maintaining naive CD4(+) and CD8(+) T cell homeostasis for subsequent optimal T cell expansion in young and old mice. To determine the significance of this finding, a week of B cell depletion in 4-mo-old mice was followed by acute viral infection with lymphocytic choriomeningitis virus Armstrong. Despite their expansion, activated and cytokine-producing CD4(+) and CD8(+) T cell numbers were still significantly reduced 1 wk later. Moreover, viral peptide-specific CD4(+) and CD8(+) T cell numbers and effector cell development were significantly reduced in mice lacking B cells, whereas lymphocytic choriomeningitis virus titers were dramatically increased. Thus, T cell function is maintained in B cell-depleted mice, but B cells are required for optimal CD4(+) and CD8(+) T cell homeostasis, activation, and effector development in vivo, particularly during responses to acute viral infection.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24928986      PMCID: PMC4290158          DOI: 10.4049/jimmunol.1302848

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  71 in total

1.  Impaired T cell immunity in B cell-deficient mice following viral central nervous system infection.

Authors:  C C Bergmann; C Ramakrishna; M Kornacki; S A Stohlman
Journal:  J Immunol       Date:  2001-08-01       Impact factor: 5.422

2.  Unusual viral infections (progressive multifocal leukoencephalopathy and cytomegalovirus disease) after high-dose chemotherapy with autologous blood stem cell rescue and peritransplantation rituximab.

Authors:  Stuart L Goldberg; Andrew L Pecora; Robert S Alter; Mark S Kroll; Scott D Rowley; Stanley E Waintraub; Kavita Imrit; Robert A Preti
Journal:  Blood       Date:  2002-02-15       Impact factor: 22.113

3.  B cell-dependent TCR diversification.

Authors:  Cristina João; Brenda M Ogle; Carlota Gay-Rabinstein; Jeffrey L Platt; Marilia Cascalho
Journal:  J Immunol       Date:  2004-04-15       Impact factor: 5.422

4.  Impaired activation of islet-reactive CD4 T cells in pancreatic lymph nodes of B cell-deficient nonobese diabetic mice.

Authors:  S A Greeley; D J Moore; H Noorchashm; L E Noto; S Y Rostami; A Schlachterman; H K Song; B Koeberlein; C F Barker; A Naji
Journal:  J Immunol       Date:  2001-10-15       Impact factor: 5.422

5.  Mouse CD20 expression and function.

Authors:  Junji Uchida; Youngkyun Lee; Minoru Hasegawa; Yinghua Liang; Alice Bradney; Julie A Oliver; Kristina Bowen; Douglas A Steeber; Karen M Haas; Jonathan C Poe; Thomas F Tedder
Journal:  Int Immunol       Date:  2004-01       Impact factor: 4.823

6.  A specific role for B cells in the generation of CD8 T cell memory by recombinant Listeria monocytogenes.

Authors:  Hao Shen; Jason K Whitmire; Xin Fan; Devon J Shedlock; Susan M Kaech; Rafi Ahmed
Journal:  J Immunol       Date:  2003-02-01       Impact factor: 5.422

7.  B cells and antibody play critical roles in the immediate defense of disseminated infection by West Nile encephalitis virus.

Authors:  Michael S Diamond; Bimmi Shrestha; Anantha Marri; Darby Mahan; Michael Engle
Journal:  J Virol       Date:  2003-02       Impact factor: 5.103

8.  RNA-transfected CD40-activated B cells induce functional T-cell responses against viral and tumor antigen targets: implications for pediatric immunotherapy.

Authors:  Christina M Coughlin; Barbara A Vance; Stephan A Grupp; Robert H Vonderheide
Journal:  Blood       Date:  2003-11-20       Impact factor: 22.113

9.  Splenic T zone development is B cell dependent.

Authors:  V N Ngo; R J Cornall; J G Cyster
Journal:  J Exp Med       Date:  2001-12-03       Impact factor: 14.307

10.  Costimulation via OX40L expressed by B cells is sufficient to determine the extent of primary CD4 cell expansion and Th2 cytokine secretion in vivo.

Authors:  Phyllis-Jean Linton; Beverly Bautista; Elana Biederman; Evan S Bradley; Judith Harbertson; Robyn M Kondrack; Ryan C Padrick; Linda M Bradley
Journal:  J Exp Med       Date:  2003-03-31       Impact factor: 14.307

View more
  21 in total

1.  A controlled inflammation and a regulatory immune system are associated with more favorable prognosis of progressive multifocal leukoencephalopathy.

Authors:  Nobuo Sanjo; Yurie Nose; Yukiko Shishido-Hara; Saneyuki Mizutani; Yoshiki Sekijima; Hitoshi Aizawa; Toru Tanizawa; Takanori Yokota
Journal:  J Neurol       Date:  2018-12-03       Impact factor: 4.849

2.  B-Cell Depletion Promotes Aortic Infiltration of Immunosuppressive Cells and Is Protective of Experimental Aortic Aneurysm.

Authors:  Basil Schaheen; Emily A Downs; Vlad Serbulea; Camila C P Almenara; Michael Spinosa; Gang Su; Yunge Zhao; Prasad Srikakulapu; Cherié Butts; Coleen A McNamara; Norbert Leitinger; Gilbert R Upchurch; Akshaya K Meher; Gorav Ailawadi
Journal:  Arterioscler Thromb Vasc Biol       Date:  2016-09-15       Impact factor: 8.311

Review 3.  Infections in Patients Receiving Multiple Sclerosis Disease-Modifying Therapies.

Authors:  Elena Grebenciucova; Amy Pruitt
Journal:  Curr Neurol Neurosci Rep       Date:  2017-09-22       Impact factor: 5.081

Review 4.  Infectious Complications of Biological and Small Molecule Targeted Immunomodulatory Therapies.

Authors:  Joshua S Davis; David Ferreira; Emma Paige; Craig Gedye; Michael Boyle
Journal:  Clin Microbiol Rev       Date:  2020-06-10       Impact factor: 26.132

5.  The molecular signature of murine T cell homeostatic proliferation reveals both inflammatory and immune inhibition patterns.

Authors:  Karen A Fortner; Jeffrey P Bond; James W Austin; Jeremy M Boss; Ralph C Budd
Journal:  J Autoimmun       Date:  2017-05-24       Impact factor: 7.094

Review 6.  Non-canonical B cell functions in transplantation.

Authors:  Jeffrey L Platt; Marilia Cascalho
Journal:  Hum Immunol       Date:  2019-04-10       Impact factor: 2.850

7.  The absence of B cells disrupts splenic and myocardial Treg homeostasis in coxsackievirus B3-induced myocarditis.

Authors:  Jing Lu; Zhihong Cen; Quan Tang; Jingwei Dong; Lin Qin; Weifeng Wu
Journal:  Clin Exp Immunol       Date:  2022-05-13       Impact factor: 4.330

8.  mRNA-LNP vaccines tuned for systemic immunization induce strong antitumor immunity by engaging splenic immune cells.

Authors:  Sanne Bevers; Sander A A Kooijmans; Elien Van de Velde; Martijn J W Evers; Sofie Seghers; Jerney J J M Gitz-Francois; Nicky C H van Kronenburg; Marcel H A M Fens; Enrico Mastrobattista; Lucie Hassler; Helena Sork; Taavi Lehto; Kariem E Ahmed; Samir El Andaloussi; Katja Fiedler; Karine Breckpot; Michael Maes; Diane Van Hoorick; Thierry Bastogne; Raymond M Schiffelers; Stefaan De Koker
Journal:  Mol Ther       Date:  2022-07-12       Impact factor: 12.910

9.  Combination therapy for inhibitor reversal in haemophilia A using monoclonal anti-CD20 and rapamycin.

Authors:  Moanaro Biswas; Geoffrey L Rogers; Alexandra Sherman; Barry J Byrne; David M Markusic; Haiyan Jiang; Roland W Herzog
Journal:  Thromb Haemost       Date:  2016-09-29       Impact factor: 5.249

Review 10.  Readapting the adaptive immune response - therapeutic strategies for atherosclerosis.

Authors:  Andrew P Sage; Ziad Mallat
Journal:  Br J Pharmacol       Date:  2017-02-01       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.